Celldex Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -36.52M-2.53M-44.80M-59.12M-81.55M-118.08M-127.20M-128.53M-93.03M-151.18M-50.88M-59.78M-70.51M-112.33M-141.43M-157.86M
Share-based Compensation 3.06M2.80M2.34M2.30M4.55M6.85M12.77M15.32M12.31M8.08M4.55M3.92M8.95M15.61M23.89M34.24M
Deferred Taxes -0.53M57.09M-53.91M66.29M28.81M-2.93M0.96M11.16M10.23M-34.62M
Gains from Sales and Divestitures 0.01M0.01M0.01M0.03M0.02M0.02M0.00M0.00M0.00M
Gains from Investment Securities 0.56M0.04M0.06M0.07M0.02M-0.01M8.11M-7.27M-6.28M-6.41M-2.17M-5.80M-7.08M-0.00M6.38M-0.02M
Asset Writedowns and Impairment 13.00M18.68M1.80M18.00M3.50M
Non-cash Items 3.31M92.60M62.80M38.60M6.09M15.00M0.43M0.57M24.70M1.48M2.10M3.26M77.10M
Cash from Operations -29.87M-30.37M-35.66M-49.78M-67.67M-101.54M-98.89M-113.04M-99.93M-75.23M-46.41M-40.40M-60.91M-103.73M-107.29M-157.80M
Depreciation, Depletion & Amortization
Amortization of Goodwill 90.98M
Amortizatization of Intangibles 0.95M3.14M1.91M1.09M1.37M1.01M1.01M1.64M0.90M1.05M1.14M0.73M3.21M-0.84M6.22M15.75M
Depreciation & Amortization (CF) 2.58M2.72M2.25M2.05M1.93M2.39M3.00M3.10M4.41M3.58M4.86M3.93M3.07M2.90M3.01M3.18M
Change in Working Capital
Change in Receivables -1.28M-0.22M-0.15M-0.13M0.45M-0.06M0.54M0.81M0.10M0.78M-2.27M0.79M-1.57M0.17M2.28M-1.93M
Change in Accured Expenses 2.70M-1.86M2.08M3.76M7.24M6.58M7.20M-4.97M-8.74M-13.11M-6.60M1.64M-4.41M3.12M9.38M11.63M
Investing Activities
Capital Expenditures 0.53M2.10M0.51M0.30M4.22M1.93M4.88M2.75M1.79M0.81M0.73M1.55M1.25M1.83M1.82M1.92M
Sales of Property, Plant and Equipment 0.85M0.08M0.07M0.22M0.02M0.34M0.02M0.06M0.03M0.07M
Acquisitions 51.65M4.59M
Change in Acquisitions & Divestments 2.67M42.38M51.00M52.36M38.89M109.23M161.09M242.79M219.24M201.47M113.17M123.60M174.95M280.67M320.60M501.71M
Cash from Investing Activities 45.09M-16.16M-2.15M-16.98M-77.42M-41.01M-50.19M68.91M46.47M29.82M17.08M-98.22M-216.16M89.94M-105.78M-290.13M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 10.00M5.00M-3.97M-11.03M2.96M
Long-Term Debt Repayments 12.50M2.96M
Change in Capital Stock
Shares Issued 0.67M1.01M36.02M83.78M295.70M1.17M188.84M13.95M51.02M29.02M16.25M170.79M269.89M4.08M216.22M432.30M
Misc.
Cash from Financing Activities -2.46M10.82M28.43M79.76M289.60M1.17M193.15M14.48M51.29M29.44M16.26M171.23M272.37M4.08M218.46M441.45M
Exchange Rate Effect -0.01M0.00M-0.01M0.00M-0.00M-0.01M0.01M
Change in Cash 12.74M-35.72M-9.39M13.00M144.50M-141.38M44.09M-29.65M-2.17M-15.98M-13.08M32.60M-4.69M-9.71M5.38M-6.46M
Beginning Cash Balance 44.26M57.00M21.29M11.90M24.90M169.40M28.02M72.11M42.46M40.29M24.31M11.23M43.84M39.14M29.43M34.81M
Free Cash Flow -30.40M-32.47M-36.17M-50.09M-71.89M-103.47M-103.76M-115.79M-101.72M-76.05M-47.15M-41.96M-62.16M-105.56M-109.11M-159.72M
Net Cash Flow 12.76M-35.72M-9.38M13.00M144.51M-141.38M44.07M-29.65M-2.17M-15.98M-13.08M32.60M-4.69M-9.71M5.38M-6.48M